Device type · DLZ
Enzyme Immunoassay, Phenobarbital
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
DLZ
Clinical Toxicology
Device class
Class II
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
6
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Enzyme Immunoassay, Phenobarbital
- Product code
- DLZ
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3660
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for DLZ
Latest FDA decisions
Ortho-Clinical Diagnostics, Inc.
K210858 · Decided Aug 13, 2021 · 143 days after receipt
Device type: Enzyme Immunoassay, Phenobarbital (DLZ) · Laboratory Medicine & Pathology
Reports received
6
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
6
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 1 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 4 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 2 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Low Test Results6
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions6
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Siemens Healthcare Diagnostics, Inc.
Z-0181-2014 · Started Aug 30, 2013 · Posted by FDA Nov 7, 2013
Reason given: Imprecision with certain lots
Cause as FDA categorized it: Nonconforming Material/Component
Z-0319-2014 · Started Jun 12, 2013 · Posted by FDA Nov 15, 2013
Reason given: Ortho Clinical Diagnostics is recalling Slide Dispense cartridges used with some VITROS Chemistry Product Slides due to slide dispense issues.
Cause as FDA categorized it: Equipment maintenance
Z-1152-2013 · Started Mar 14, 2013 · Posted by FDA Apr 19, 2013
Reason given: Ortho Clinical Diagnostics (OCD) received customer complaints of intermittent imprecision, outliers, or shifts in accuracy and control fluid values outside of expected intervals when using VITROS Chemistry Products PHBR Slides. OCD's investigation confirmed that positively biased values for patient samples could be...
Cause as FDA categorized it: Unknown/Undetermined by firm
Siemens Healthcare Diagnostics, Inc.
Z-0664-2013 · Started Dec 10, 2012 · Posted by FDA Jan 10, 2013
Reason given: Firm has confirmed higher imprecision with the recalled lots on Beckman Coulter AU(R) Systems and the Syva(R) Emit(R) 2000 Phenobarbital (4D019UL) lots E1, E2, and E3 as an application if the AU(R) System is used, the issue may be experienced. Firm has found that within-run imprecision of the recalled lots frequency...
Cause as FDA categorized it: Nonconforming Material/Component
Z-1118-2013 · Started Nov 16, 2012 · Posted by FDA Apr 15, 2013
Reason given: Abbott Diagnostics is recalling Clinical Chemistry Phenobarbital reagent lots 62299UN12 and 85773UN12 due to imprecision issues which increase with the age of the reagent lot. The imprecision of the Phenobarbital assay is d 7% Total CV%; however, internal testing confirmed CVs up to approximately 12% for in-date...
Cause as FDA categorized it: Nonconforming Material/Component
Siemens Healthcare Diagnostics, Inc.
Z-0030-2013 · Started Jul 30, 2012 · Posted by FDA Oct 10, 2012
Reason given: Firm has confirmed highter imprecision with the recalled lots on Beckman Coulter AU(R) Systems. Also, if the Syva(R) Emit(R) 2000 Phenobartbital Assay (4D019UL) lots D4, D5, D6, and/or D7 as an application on AU(R) Systems is used, the issue may be experienced. Firm has found that within-run imprecison of the recalled...
Cause as FDA categorized it: Nonconforming Material/Component
Z-1117-2012 · Started Jun 23, 2011 · Posted by FDA Feb 28, 2012
Reason given: Ortho Clinical Diagnostics (OCD) received customer complaints of intermittent imprecision, outliers, or shifts in control fluid values when using various lots of VITROS Chemistry Products PHBR Slides (Phenobarbital) from Coating 0053.
Cause as FDA categorized it: Nonconforming Material/Component
Z-1173-2012 · Started Aug 11, 2009 · Posted by FDA Mar 6, 2012
Reason given: The recall was initiated because Beckman Coulter has confirmed reports of variability in results with the lots of Phenobarbital (PHE) reagent and calibrator.
Cause as FDA categorized it: Nonconforming Material/Component
Showing the 8 newest of 9 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.